Dana J. Hawkinson, MD

Professional Background

After completing Infectious Disease fellowship at the Univeristy of Kansas Medical Center in 2010 I became faculty, and have been at the University of Kansas Medical Center since. In addition to general infectious disease duties, either on the inpatient consult service or the outpatient clinics, I am the medical director for the Infection Control and Prevention (IPAC) program. This duty includes working with my IPAC team in collecting data and providing best practices guidance to reduce healthcare associated infecitons within our health system. I work in scientifiic and medical communication to provide information to our patients and the general public through the health system on various topics which are on the forefront and affecting our daily lives.

• BS, St. Ambrose Univ.
• MA, Microbiology, Univ. of Kansas, Lawrence, KS
• MD, Univ. of Kansas-Medical Ctr.
• Residency, Internal Medicine, University of Kansas Medical Center, Kansas City, KS
• Clinical Fellowship, Infectious Disease, University of Kansas Medical Center, Kansas City, KS

• Physician, Kansas State Board of Healing Arts
• Physician, Kansas State Board of Healing Arts

---

• Hawkinson DanaJoseph, Ison MG. 2016. Respiratory Viruses: Influenza, RSV, and Adenovirus in Kidney Transplantation.. Seminars in nephrology, 36 (5), 417-427
• Beaird OE, Freifeld A, Ison MG, Lawrence SJ, Theodoropoulos N, Clark NM, Razonable RR, Alangaden G, Miller R, Smith J, Young JA, Hawkinson DanaJoseph, Pursell K, Kaul DR. 2016. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.. Transplant infectious disease : an official journal of the Transplantation Society, 18 (2), 210-5
• Kosoy OI, Lambert AJ, Hawkinson DanaJoseph, Pastula DM, Goldsmith CS, Hunt DC, Staples JE. 2015. Novel thogotovirus associated with febrile illness and death, United States, 2014.. Emerging infectious diseases, 21 (5), 760-4
• Hawkinson DanaJoseph, Abhyankar SunilH, Aljitawi O, Ganguly Siddhartha, McGuirk JosephP, Horvat RebeccaT. 2013. Delayed RSV diagnosis in a stem cell transplant population due to mutations that result in negative polymerase chain reaction.. Diagnostic microbiology and infectious disease, 75 (4), 426-30
• Horvat RebeccaT, El Atrouni WissamIssam, Hammoud KassemAssaad, Hawkinson DanaJoseph, Cowden S. 2013. Reply to "Mistaken identity of Brucella infection".. Journal of clinical microbiology, 51 (6), 2012
• Borrego-Diaz E, Mathew R, Hawkinson DanaJoseph, Esfandyari Tuba, Liu Z, Lee Phil, Farassati F. 2012. Pro-oncogenic cell signaling machinery as a target for oncolytic viruses.. Current pharmaceutical biotechnology, 13 (9), 1742-9
• Horvat RebeccaT, El Atrouni WissamIssam, Hammoud KassemAssaad, Hawkinson DanaJoseph, Cowden S. 2011. Ribosomal RNA sequence analysis of Brucella infection misidentified as Ochrobactrum anthropi infection.. Journal of clinical microbiology, 49 (3), 1165-8
• Fujita M, Hawkinson DanaJoseph, King KV, Hall DH, Sakamoto H, Buechner M. 2003. The role of the ELAV homologue EXC-7 in the development of the Caenorhabditis elegans excretory canals.. Developmental biology, 256 (2), 290-301